PACT Pharma
Personalized cancer therapy through precision genome engineering
South San Francisco, United States · Founded 2017 · $170.0M raised
- Headquarters
- South San Francisco, California
- Employees
- 51–200
- Founded
- 2017
- Business Model
- B2B
- Website
- pactpharma.com
- Total Funding
- $170.0M
- Last Round
- $75.0M Series CMar 2024
- Rounds
- 2
About
PACT Pharma is a clinical-stage biopharma pioneering personalized neoantigen TCR therapies for solid tumors. PACT^NV platform uses non-viral CRISPR gene editing. Lead NeoTCR-P1.
Summary
PACT Pharma is a Biotech company based in South San Francisco, United States, founded in 2017. It has raised $170.0M in total across 2 rounds, most recently a $75.0M Series C round in Mar 2024. Investors include GV, Vida Ventures and AbbVie Ventures.
Funding History
Mar 2024
Sign up to see all 2 rounds
Series B through Series C — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/pact-pharma"><img src="https://indexed.vc/api/badge/company/pact-pharma" alt="PACT Pharma on Indexed.vc" width="260" height="76" /></a>